Clinical Trials Browser

Completed × Cell- and Tissue-Based Therapy × 90 days × Clear all

NCT05322330 2026-06-02

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, B-Cell